VEO Ophthalmics Partners with PeriVision to Bring VisionOne VR Visual Field Platform to US
VEO Ophthalmics announced the availability of the VisionOne VR Visual Field platform in the United States through a strategic partnership with PeriVision. This collaboration brings Switzerland-based PeriVision’s patented AI visual field-testing algorithm (SORS) to US clinicians.
The VisionOne system leverages PeriVision’s proprietary 'Sequentially Optimized Reconstruction Strategy' (SORS) algorithm to enhance the precision and speed of visual field assessments. By optimizing the testing sequence in real time, the platform is designed to reduce test duration while maintaining a high correlation with gold-standard methods and improve test-retest reliability.
Through VisionOne, ophthalmologists and optometrists can conduct visual field exams using portable VR headsets and access results through a secure cloud-based analytics platform. AI algorithms automate test assistance, data interpretation, and quality control, empowering clinicians to streamline workflows while enhancing patient experience.
“Just last year, a publication estimated that from 2020 to 2035, the ophthalmology workforce is expected to shrink by more than 2,600 full-time equivalents (FTE), while demand will grow by around 5,000 FTE,” said Patrick Kessel, CEO of PeriVision. “VisionOne addresses this drastically growing need for more efficient and patient-friendly ophthalmic testing. We are very excited to partner with VEO Ophthalmics to deliver our breakthrough technology to eye care professionals across the US”
Ron Gilliland, President and CEO of VEO Ophthalmics, added, “VisionOne uniquely allows eye care professionals to reduce visual field testing time and maintain accuracy when diagnosing and monitoring glaucoma with advanced AI algorithms. We are very pleased to partner with PeriVision and bring this technology to eye care professionals to enhance patient care.”
Under the exclusive US distribution agreement, VEO Ophthalmics will lead the introduction and commercialization of VisionOne across the American eye care market.